glp-1 insurance coverage 2026 Weight loss drugs' high costs prompt Cigna to cut employee health plan Insurance Coverage for GLP-1 Weight

Can You (or Should You) Break Through the GLP-1 Weight Loss Plateau

The National Psoriasis Foundation Primer on GLP-1 Receptor Agonists in Psoriasis: A Review

Again, orforglipron is still being studied and in late clinical trials, but heres the expected timeline: Eli Lilly plans to submit it to the FDA in late 2025 for approval for weight loss in adults with a BMI of 30 or higher, or 27 and higher with a related health condition

Meta-analyses of randomized controlled trials found that magnesium supplementation may support healthy insulin sensitivity and glucose metabolism, outcomes relevant to GLP-1 users optimizing their metabolic health

References Bray, G

When food and waste sit in the small intestine for longer than they should, it creates an environment where bacteria can can overgrow